Vical to Present at the 28th Annual ROTH Conference

SAN DIEGO, March 09, 2016 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq: VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook on Wednesday, March 16, at 7:30 a.m. PDT at the ROTH Capital Partners 28th Annual ROTH Conference (Newport Beach, California March 13 – 16). A webcast of the company’s presentation will be available live and archived through the Events & Presentations page in the Investors section of the Vical website at www.vical.com.

About Vical

Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on its patented DNA delivery technologies and other therapeutic approaches. Additional information on Vical is available at www.vical.com.

Contact:
Andrew Hopkins
(858) 646-1127
Website:  www.vical.com

You May Also Be Interested In

• First Energy Africa Oil Corp. Strengthens Board with Appointment of Industry Veterans Simon Akit and Frederick Kozak
• Hennick Humber Hospital in Canada has selected Sectra One Cloud to speed up patient diagnostics with improved radiology workflows
• Tineco Strengthens Global Leadership Following Category-Topping Prime Day Results